Posters Thursday 30 January
Posters - Thursday 30 January
TOPIC: Fluid biomarkers
19 - Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies.
Lucy Gibson
228 - Maximizing sensitivity of cerebrospinal fluid (CSF) biomarkers to detect Alzheimer’s co-pathology in autopsy-confirmed Lewy Body Disease (LBD)
David Irwin
125 - Plasma biomarkers and disease prognosis in mild cognitive impairment with Lewy bodies
Paul Donaghy
290 - Characterization of DLB plasma proteome
James Leverenz
197 - Plasma Biomarkers of Alzheimer’s Pathology, neuroinflammation and neurodegeneration Identify Prodromal Dementia with Lewy bodies
Aline Delva
14 - Plasma small extracellular vesicles enriched for microglial origin as potential blood-based diagnostic biomarkers for Dementia with Lewy bodies
Anto Rajamani
241 - Plasma Dopa-decarboxylase (DDC) is elevated in Lewy Body Dementia and is associated with cognitive impairment at baseline and longitudinal decline.
Leonidas Chouliaras
243 - Diagnostic Performance of the RT-QuIC α-synuclein in Dementia with Lewy Bodies from the AlphaLewyMA Cohort
Olivier Bousiges
247 - Plasma Phosphorylated-tau 217 and 231 are elevated in Lewy Body Dementia and have limited accuracy in differentiating Lewy Body dementia from Alzheimer’s disease.
Leonidas Chouliaras
252 - The CSF profile of pathological Tau and P-Tau and normal Aβ42 corresponds mainly to patients with comorbid AD and DLB
Olivier Bousiges
319 - Testing the alpha-synuclein seed amplification assay in dementia with Lewy bodies across European countries
Rakesh Kumar
347 - A longitudinal study of blood biomarkers of inflammation and neurodegeneration in dementia with Lewy bodies
Paula Loveland
348 - Blood biomarkers of inflammation and neurodegeneration in dementia with Lewy bodies
Paula Loveland
359 - Plasma brain-derived tau and phosphorylated tau 217 are associated with alzheimer’s co-pathology in dementia with lewy bodies
Andreja Emeršič
363 - Changed in levels of plasmin-related proteins and brain-derived neurotrophic factor are associated with regional brain atrophy in alpha-synucleinopathies
Zuzana Nedelska
443 - Alzheimer biomarkers in spinal fluid as a measurement of progression and severity of Dementia of Lewy bodies
Anne-Mette Hejl
449 - Longitudinal Measurements of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Neuronal Damage in Dementia with Lewy Bodies
Juliette Alphen
458 - Assessment of the Novel Neuronal Synuclein Disease Staging System in Stratifying Dementia with Lewy Bodies Patients
Maria Camila Gonzalez Velez
463 - Platelet-derived miRNAs as biomarkers for dementia with Lewy bodies
Katrin Beyer
156 - Novel plasma biomarkers to differentiate dementia with Lewy bodies from Alzheimer’s disease
Woo Suk Yang
165 - Evaluating multiplex proximity extension assays in plasma to identify patterns of inflammation associated with diagnosis and prognosis in DLB
Peter Swann
175 - Interest of α-synuclein seed amplification assay (SAA) in patients with dementia with Lewy bodies difficult to diagnose
Candice Muller
185 - Early blood-based identification of Lewy body disease and Alzheimer's disease
Niels Okkels
TOPIC: Imaging/neurophysiology biomarkers
221 - Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder
Shady Rahayel
159 - Influence of alpha-synuclein pathology on brain FDG-PET pattern in amnestic MCI
Samir Abu Rumeileh
350 - BEHOLD (BioEnergetic Hallmarks of Lewy Body Dementia (LBD)): Background and design of multimodal neuroimaging study to elucidate mitochondrial/bioenergetic dysfunction as LBD develops
Sarah Berman
148 - Neuropathological correlates of basal forebrain atrophy in Alzheimer’s and Lewy body disease
Julia Schumacher
149 - Quantitative Susceptibility Mapping differences in Lewy body dementia
Rimona Weil
320 - Evaluating white matter microglial activation with [11C]-PK11195C PET in Lewy body dementia and its clinical and biomarker associations
Elijah Mak
269 - Investigation of the Glymphatic System as a prognostic marker for Dementia with Lewy bodies
Christina Tremblay
189 - Brain Connectivity Alterations in Prodromal Synucleinopathy: Evidence from the Largest International Neuroimaging Study of Individuals with Idiopathic REM Sleep Behavior Disorder
Christina Tremblay
39 - Brain network connectivity underlying neuropsychiatric symptoms in prodromal Lewy body dementia.
Laura Wright
215 - The clinical use of indicative imaging biomarkers in DLB and MCI-LB: A Delphi consensus study
Paul Donaghy
230 - Semiquantitative Analysis of the Longitudinal 123I-FP-CIT SPECT in Dementia with Lewy Bodies
Toji Miyagawa
285 - Atrophy of individual thalamic nuclei in Lewy body dementias and Alzheimer’s disease revealed in vivo with ultra-high resolution MRI
Elizabeth McKiernan
323 - Comparing patterns of microglial activation between dementia with Lewy bodies and Alzheimer’s disease
Elijah Mak
355 - Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer’s disease copathologies
Elijah Mak
373 - Characterization of oscillatory and aperiodic resting-state EEG spectrum in Neurodegenerative Diseases: A multicentric study
Alberto Jaramillo-Jimenez
424 - Cortical inhibitory and facilitatory alterations in the continuum of alpha-synucleinopathies
Andrea Pilotto
441 - An international neuroimaging consortium for lewy body disorders
Ysbrand Werf
453 - Regional Gene Expression Patterns and Connectivity Underlie Cortical Thinning in Dementia with Lewy Bodies
Aline Delva
466 - Non-invasive imaging correlate of central cholinergic degeneration and its relation to clinical expression and conversion in prodromal and early Parkinson’s disease
Tamir Eisenstein
274 - Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson’s disease
Anna Goodheart
292 - Alpha-synuclein radioligand development: Pipeline to human PET imaging
Stephen Gomperts
330 - Cortical dopaminergic vulnerability across Alzheimer’s and Lewy Bodies spectrum: a 123I-FP-CIT study
Alice Galli
35 - A systematic review of diffusion tensor imaging and tractography in Dementia with Lewy Bodies and Parkinson’s Disease Dementia.
Axel AS Laurell
54 - Macro-and microstructural white matter changes in Lewy Body Dementia
Naomi Hannaway
104 - Novel application of high-density task-based EEG in DLB
Shannon Chiu
131 - A spatial covariance 123I-5IA-85380 SPECT study of α4β2 nicotinic receptors in dementia with Lewy bodies
Judith Harrison
157 - Cortical Thickness of Prodromal DLB and AD: A Retrospective ADNI Cohort
Dunia Alhamad
201 - Distribution of perivascular spaces in dementia with Lewy bodies: a cohort study
Jenny Jia Ju
276 - Functional connectivity changes associated with depression in Dementia with Lewy bodies
Manon Querry
277 - Cerebrovascular disease in cholinergic white matter and associations with neurodegeneration and cognition along the Lewy body continuum
Anna Rennie
280 - Connectivity-based classifier model as a promising biomarker for cognitive fluctuations in dementia with Lewy bodies
Jagan Pillai
281 - Individual hippocampal subfield atrophy in Lewy body dementias revealed with ultra-high-resolution MRI
Elizabeth McKiernan
298 - Heterogeneity of cholinergic dysfunction in early cognitive impairment due to Lewy body disease
Jahfer Hasoon
321 - The Frontoparietal and Salience Networks in Dementia with Lewy bodies: a Functional Connectivity Impairment Related to Disease Progression Towards Dementia
Vincent Gabriel
327 - Visually Evoke MEG in Dementia with Lewy Bodies
Li Su
336 - Neuropsychiatric symptoms and microglial activation in dementia with Lewy bodies and Alzheimer’s disease: A Positron Emission Tomography study
Anastasia Mirza-Davies
387 - Dopaminergic connectivity changes in prodromal and early alpha-synuclein spectrum
Alice Galli
415 - REM Without Atonia Index is Inversely Correlated with Caudate Asymmetry in Dementia with Lewy Bodies
Chiara Giuseppina Bonomi
480 - Personalized rTMS Targeting the Anterior Insular Cortex in Dementia with Lewy Bodies: Preliminary Evidence from Cognitive Evoked-Related Potential and Behavioral Sustained Attention to Response Task
Golda Gommel
119 - Systematic Review of Cardiovascular Autonomic Dysfunction in Alpha-Synucleinopathies
Ciara Gibbons
TOPIC: Fluid biomarkers
322 - Influence of α-synuclein on glucose metabolism in the Alzheimer’s disease continuum: analyses of α-synuclein Seed Amplification Assay and FDG-PET
Elijah Mak
57 - The Association between Plasma Biomarkers and Survival in Lewy Body Dementias
Jerry HK Tan